Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533591) titled 'Clinical Study of Chemogenetic Gene Therapy With AAV Virus for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus' on April 9.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition:
Parkinson's Disease (PD)
Intervention:
Genetic: gene therapy
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: May 2026
Target Sample Size: 6
Countries of Recruitment:
Chi...